The rise of the Delta variant has prompted a thorny question: Do we need a booster dose of the vaccine for Covid-19? Vaccine makers think so, but regulators are yet to be convinced.
Principles are also at stake: Should richer countries be talking about administering extra doses when so many people around the world are yet to receive even a single shot?
Gue ... Show More
Apr 15
Trump’s Risky Strategy to Blockade Iran’s Blockade
Over a month into a war with Iran that has no clear end, President Trump has enforced a blockade, which went into effect on Monday at the Strait of Hormuz. The New York Times reporters David E. Sanger, Rebecca F. Elliott and Eric Schmitt discuss the strategy behind the blockade, ... Show More
27m 18s
Apr 14
The Workers Letting A.I. Do Their Jobs
Since the release of generative A.I., questions have been raised about how it would change our lives and jobs. Now, many software developers who were early adopters of the technology have outsourced so many tasks that they barely program at all. Clive Thompson, who writes about t ... Show More
36m 30s
Jan 2021
What's with the hold-up with the Pfizer vaccine?
The vaccine hopes of millions of people worldwide are hanging on the Pfizer vaccine, but the supply of the shot is facing delays.
Why? Well, it relies on a whole lot of things that have never happened before all happening at once, in perfect sequence.
It's the first approved mRNA ... Show More
10m 52s
Dec 2020
Vaccine hesitancy, the next pandemic hurdle
As the Pfizer-BioNTech vaccine rolls out across the country, and other vaccines await imminent regulatory approval, many public health experts are focusing on the issue of vaccine hesitancy.
Canada's Chief Public Health Officer Dr. Theresa Tam has spoken out about the "moveable m ... Show More
31m 47s